I’m answering my own question here.
These are the questions I asked my mom’s medical team:
What does it mean that my mom’s genetic testing came back with no mutations? Does that tell us anything about what treatments are more effective than others for her? How does that figure into the trial on Cabozantinib? Does the test result affect the possible efficacy of the drug on my mom?
Here’s their response:
These results have no impact on her current trial, either candidacy or efficacy. It simply means her tumor has no specific mutations. This is neither good not bad. And it really doesn’t direct or guide future treatments other than to say she would not be a candidate for a trial using a drug that targets a mutation she doesn’t have. We can discuss more at her next appointment. But bottom line it has no immediate implications on her treatment.